CompaniesFormation Biologics

Formation Biologics

defunct

About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (3)

Total Trials

3

As Lead Sponsor

1

As Collaborator

2

Total Enrollment

89

By Phase

PHASE1: 2PHASE1/PHASE2: 1

By Status

COMPLETED: 2TERMINATED: 1

Clinical Trials Pipeline3 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2016

2017

2018

2019

2020

2021

2022

2023

Today

Hover over trial bars to see details

Recent Trials

NCT03895112Collaborator

MPN-RC 118 AVID200 in Myelofibrosis

PHASE1Completed

21 participants

Started: Feb 15, 2019 · Completed: May 16, 2022

NCT03834662Collaborator

A Trial of AVID200, a Transforming Growth Factor β (TGFβ) Inhibitor, in Patients Malignancies

PHASE1Completed

19 participants

Started: Jan 7, 2019 · Completed: Feb 19, 2020

NCT03094169Lead Sponsor

AVID100 in Advanced Epithelial Carcinomas

PHASE1/PHASE2Terminated

49 participants

Started: Feb 1, 2017 · Completed: Jan 30, 2021

Funding History (1)

D

Jun 26, 2015